Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 25/8/2019
SIETES contiene 92797 citas

 
 
 1 a 4 de 4 
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Haight BR, Learned SM, Lafont CM, Fudala PJ, Zhao Y, Garofalo AS, Greenwald MK, Nadipelli VR, Linq W, Heidbreder C, RB-US-13-0001 Study Investigators. Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 2019;393:23 de febrero. [Ref.ID 103111]
2.
Montoya ID, Gorelick DA, Preston K L, Schroeder JR, Umbricht A, Cheskin LJ, Lange R, Contoreggi C, Johnson RE, Fudala PJ. Randomized trial of buprenorphine for treatment of concurrent opiate and cocaine dependence. Clin Pharmacol Ther 2004;75:34-48. [Ref.ID 68918]
3.Tiene citas relacionadas
Fudala PJ, Bridge TP, Herbert S, Williford WO, Chiang N, Jones K, Collins J, Raisch D, Casadonte P, Goldsmith RJ, Ling W, Malkerneker U, McNicholas L, Renner J, Stine S, Tusel D, for the Buprenorphine/Naloxone Collaborative Study Group. Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone. N Engl J Med 2003;349:949-58. [Ref.ID 67304]
4. Cita con resumen
Johnson RE, Jaffe JH, Fudala PJ. A controlled trial of buprenorphine treatment for opioid dependence. JAMA 1992;267:2750-5. [Ref.ID 17499]
Seleccionar todas
 
 1 a 4 de 4